Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.

@article{Gupta2005HepaticAE,
  title={Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.},
  author={Sanjay Gupta and Marcella M. Johnson and Ravi Murthy and Kamran Ahrar and Michael J. Wallace and David C. Madoff and Stephen E. McRae and Marshall E. Hicks and S Harinarayana Rao and J. Nicholas Vauthey and Jaffer A. Ajani and James C. Yao},
  journal={Cancer},
  year={2005},
  volume={104 8},
  pages={1590-602}
}
BACKGROUND The objective of this study was to determine the prognostic variables that influence response and survival in patients with metastatic neuroendocrine tumors who are treated with hepatic arterial embolization (HAE) or chemoembolization (HACE). METHODS Patients with metastatic neuroendocrine tumors who underwent HAE or HACE were included in this retrospective study. Follow-up imaging studies were compared with baseline imaging to determine the radiologic response. Progression-free… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 148 extracted citations

Primary and Metastatic Liver Tumors

Springer International Publishing • 2018
View 5 Excerpts
Highly Influenced

Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization?

Journal of Gastrointestinal Surgery • 2008
View 10 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…